Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

Clinical trial NCT00498303 · COMPLETED

Trial details

NCT number: NCT00498303
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza Vaccine

Start date: 2007-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.